Does testosterone therapy increase resting heart rate and alter heart‑rate variability (HRV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Testosterone Does Not Cause Increased Resting Heart Rate or Adverse Changes in Heart Rate Variability

Testosterone therapy at physiologic replacement doses does not increase resting heart rate and actually improves heart rate variability (HRV) in men with testosterone deficiency, suggesting beneficial effects on cardiac autonomic function rather than harm. 1

Evidence from Guidelines and FDA Labeling

The comprehensive New England Journal of Medicine guideline on testosterone replacement therapy risks does not list increased heart rate or altered HRV as recognized adverse effects 1. The documented cardiovascular risks focus on:

  • Erythrocytosis (polycythemia)
  • Fluid retention
  • Potential cardiovascular events (though evidence suggests neutral or beneficial effects)

The FDA drug label for intramuscular testosterone similarly does not identify heart rate changes or HRV alterations as warnings or adverse effects 2. The cardiovascular warnings center on edema in patients with pre-existing cardiac disease, not chronotropic effects.

Research Evidence Shows Beneficial Effects on HRV

The highest quality research directly addressing this question demonstrates testosterone replacement improves HRV parameters in testosterone-deficient men:

Key Study Findings:

In men with metabolic syndrome and testosterone deficiency, 9-week testosterone therapy significantly improved multiple HRV parameters 3:

  • Increased SDNN (standard deviation of normal-to-normal intervals)
  • Increased SDANN
  • Increased total power, low-frequency, and ultra-low-frequency domains
  • These improvements suggest enhanced parasympathetic tone and better autonomic balance

A parallel study confirmed testosterone therapy improved heart rate turbulence (another autonomic marker) without adverse chronotropic effects 4.

In orchiectomized rats, chronic testosterone replacement restored both ejection fraction and HRV that were impaired by testosterone deficiency 5. This demonstrates testosterone deficiency itself impairs cardiac autonomic function, which testosterone corrects rather than worsens.

Clinical Interpretation

The Mechanism:

Testosterone deficiency is associated with:

  • Impaired cardiac autonomic function
  • Reduced HRV
  • Increased cardiovascular risk

Physiologic testosterone replacement restores normal autonomic balance rather than disrupting it.

Important Caveats:

  1. Dose matters: The beneficial effects occur with physiologic replacement doses. Supraphysiologic doses (as used in performance enhancement) may have different effects 1.

  2. Baseline testosterone status matters: The improvements in HRV are seen in testosterone-deficient men. The effects in eugonadal men are less clear 6.

  3. Individual variability exists: One study showed considerable individual variation in the HRV-testosterone relationship 7, though aggregate data still showed the expected negative correlation between HRV and testosterone-to-cortisol ratio during stress.

Bottom Line for Clinical Practice

Do not attribute increased heart rate or altered HRV to appropriately dosed testosterone replacement therapy. If a patient on testosterone develops tachycardia or HRV changes, look for other causes:

  • Erythrocytosis (check hematocrit) 1, 2
  • Fluid overload in susceptible patients 2
  • Concurrent medications or conditions
  • Supraphysiologic dosing

The evidence consistently shows testosterone replacement at physiologic doses improves rather than impairs cardiac autonomic function in testosterone-deficient men 5, 3, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.